Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14705-8 Doxepin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Doxepin [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14705-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Doxepin SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Adapin; Aponal; Dox; Doxpin; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinequan; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14706-6 Doxepin SCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE Doxepin [Moles/volume] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14706-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Doxepin Ur-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Adapin; Aponal; Dox; Doxpin; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Sinequan; Substance concentration; UA; UR; Urn 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14707-4 Doxepin+Nordoxepin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Doxepin+Nordoxepin [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14707-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Doxepin+Nor SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Adapin; Aponal; Desdoxepin; Desdoxepine; Desmeth; Desmethyl; Desmethyldox; Desmethyldoxepin; Dox; Doxepin metabolite; Doxpin; DRUG/TOXICOLOGY; Drugs; Level; N-desmethyldoxepin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinequan; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14708-2 Endomysium Ab Titr Ser Pt SemiQn &nbsp; &nbsp; ACTIVE Endomysium Ab [Titer] in Serum &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; titer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 14708-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Endomysium Ab Titr Ser &nbsp; &nbsp; &nbsp; Y &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EMA; Endomysial; Gastro; Gastroenterology; GI; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Transglutaminase; Ttr; UniversalLabOrders 2.75 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {titer} &nbsp; &nbsp; &nbsp; 0
14709-0 Eosinophils/Leukocytes NFr Bronchial Pt Qn Manual count &nbsp; ACTIVE Eosinophils/Leukocytes in Bronchial specimen by Manual count &nbsp; NAM DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 14709-0 &nbsp; Manual count &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Eosinophil NFr Bronch Manual &nbsp; &nbsp; &nbsp; Y &nbsp; Bro; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells 2.79 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
1471-2 Follitropin^1H post dose gonadotropin releasing hormone MCnc Ser/Plas Pt Qn &nbsp; &nbsp; DISCOURAGED Follitropin [Mass/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1471-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 FSH 1h p GnRH SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 1 hour; 1.0Hr; 1h p GnRH; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; GHR; GnRH; Horm; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Mass concentration; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14710-8 Ephedrine+Pseudoephedrine PrThr Gast fld Pt Ord &nbsp; &nbsp; ACTIVE ePHEDrine+Pseudoephedrine [Presence] in Gastric fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14710-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Ephedrin+Pseudo Gast Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Cenafed; DRUG/TOXICOLOGY; Drugs; Ectasule; Ephedrin+Pseudo; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; Pseudoephed; QL; Qual; Qualitative; Random; Screen; Sudafed 2.56 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14711-6 EPINEPHrine SCnc Plas Pt Qn &nbsp; &nbsp; ACTIVE EPINEPHrine [Moles/volume] in Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14711-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Epineph Plas-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Adrenalin; Adrenaline; Adreneline; Chemistry; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14712-4 EPINEPHrine SRat Urine 24H Qn &nbsp; &nbsp; ACTIVE EPINEPHrine [Moles/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/24 H &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14712-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Epineph 24h Ur-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Adrenalin; Adrenaline; Adreneline; Chemistry; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/(24.h) &nbsp; &nbsp; &nbsp; 0
14713-2 Erythrocytes NCnc Pericard fld Pt Qn Manual count &nbsp; ACTIVE Erythrocytes [#/volume] in Pericardial fluid by Manual count &nbsp; MIN DefinitionDescription &nbsp; &nbsp; 10*6/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 14713-2 &nbsp; Manual count &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 RBC # Pcar Manual &nbsp; &nbsp; &nbsp; Y &nbsp; #; ABS; absolute; absolutes; Cardio; Cardiology; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; Heart Disease; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; /uL &nbsp; &nbsp; &nbsp; 0
14714-0 Erythropoietin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; DISCOURAGED Erythropoietin (EPO) [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14714-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 EPO SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; EPO; Epoetin; Erthropoyetin; Erythropoetin; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14715-7 Estradiol SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Estradiol (E2) [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14715-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Estradiol SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 17-beta estradiol; Chemistry; E2; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Oestradiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14716-5 Estriol SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Estriol (E3) [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14716-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Estriol SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; E3; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14717-3 Estriol SCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE Estriol (E3) [Moles/volume] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14717-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Estriol Ur-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; E3; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14718-1 Estriol SRat Urine 24H Qn &nbsp; &nbsp; ACTIVE Estriol (E3) [Moles/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/24 H &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14718-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Estriol 24h Ur-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Chemistry; E3; Gyn; Gynecology; OB; ObGyn; Obstetrics; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/(24.h) &nbsp; &nbsp; &nbsp; 0
14719-9 Ethanol SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Ethanol [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14719-9 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Ethanol SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Alc; Alcohol; DRUG/TOXICOLOGY; Drugs; Ethyl alcohol; EtOH; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
1472-0 Follitropin^2H post 100 ug luteinizing releasing hormone IV MCnc Ser/Plas Pt Qn &nbsp; &nbsp; DISCOURAGED Follitropin [Mass/volume] in Serum or Plasma --2 hours post 100 ug luteinizing releasing hormone IV &nbsp; NAM DefinitionDescription &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1472-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 FSH 2h p 100 ug LRH IV SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 120 min; 120 minutes; 120min; 2 hours; 2h p 100 ug LRH IV; After; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; Horm; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.69 1 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14720-7 Ethosuximide SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Ethosuximide [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14720-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Ethosuximide SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Zarontin 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14721-5 Ethylene glycol SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Ethylene glycol [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14721-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Ethylene Glycol SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14722-3 Extractable nuclear Ab PrThr Ser Pt Ord &nbsp; &nbsp; ACTIVE Extractable nuclear Ab [Presence] in Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 14722-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 ENA Ab Ser Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; ENA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14723-1 Ferritin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Ferritin [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14723-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Ferritin SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Ferr; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14724-9 Ferritin Imp Bld Pt Nom &nbsp; &nbsp; ACTIVE Ferritin [Interpretation] in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14724-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ferritin Bld-Imp &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Blood; Chemistry; Ferr; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; WB; Whole blood 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
14725-6 Observation Type Body fld Pt Nom &nbsp; &nbsp; ACTIVE [Type] of Body fluid &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SPEC &nbsp; 14725-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Body fld type &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Nominal; Point in time; Random; SPEC; Typ 2.81 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.81: COMPONENT: Changed the component to observation to align with other changes for the LOINC ontology work.; 0
14726-4 Fluoride SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Fluoride [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14726-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Fluoride SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Fl; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14727-2 FLUoxetine PrThr Gast fld Pt Ord &nbsp; &nbsp; ACTIVE FLUoxetine [Presence] in Gastric fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14727-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 FLUoxetine Gast Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; Prozac; QL; Qual; Qualitative; Random; Screen 2.56 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
108,248 results found